Impaired endothelial function in systemic lupus erythematosus

Abstract

Systemic lupus erythematosus (SLE) patients suffer from excess cardiac deaths due to accelerated atherosclerosis. Endothelial dysfunction is a marker of early atherosclerosis. We tested the hypothesis that SLE patients have impaired endothelial function and assessed the relationship between endothelial function and clinical outcome over the subsequent five years. Thirty-six female SLE patients were compared with 22 healthy age and sex matched controls. Endothelial dependent vasodilatation (EDD) was assessed at the brachial artery in response to shear stress. Endotheliumindependent dilatation induced by glyceryl trinitrate was also measured. Patients were followed for up to five years and the development of damage in the cardiovascular and other systems recorded. SLE patients showed significantly impaired endothelial function (median EDD 5.6%, IQR 3.1–7.2%) compared with healthy controls (median EDD 8.0%, IQR 6.3–9.3%; P = 0.001). Endothelium independent dilatation did not differ between the two groups. Endothelial function was significantly worse in postmenopausal compared with premenopausal women (median EDD 6.6%, IQR 3.9–7.8% versus 3.1%, IQR 2.6–5.1%; P = 0.016). Total cholesterol was inversely correlated with endothelial function in SLE patients (Spearman correlation r = -0.422, P = 0.025). There was no relationship between endothelial function and the development of damage in any organ system, including the cardiovascular system during patient follow-up. Patients with SLE have impaired endothelial function. In the small number of patients studied impaired endothelial function was not associated with a worse cardiovascular outcome over five years.

Keywords

atherosclerosis endothelium systemic lupus erythematosus

Get full access to this article

View all access options for this article.

References

Urowitz MB , Bookman AA , Koehler BE et al. The bimodal mortality pattern of systemic lupus erythematosus. Am J Med 1976; 60: 221–225.

Manzi S , Meilahn EN , Rairie JE et al. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. Am J Epidemiol 1997; 145: 408–415.

Roman MJ , Salmon JE , Sobel R et al. Prevalence and relation to risk factors of carotid atherosclerosis and left ventricular hypertrophy in systemic lupus erythematosus and antiphospholipid antibody syndrome. Am J Cardiol 2001; 87: 663–666, A11–A11.

Bruce IN , Urowitz MB , Gladman DD et al. Risk factors for coronary heart disease in women with systemic lupus erythematosus: the Toronto Risk Factor Study. Arthritis Rheum 2003; 48: 3159–3167.

Celermajer DS , Sorensen KE , Gooch VM et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992; 340: 1111–1115.

Celermajer DS , Sorensen KE , Georgakopoulos D et al. Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults. Circulation 1993; 88: 2149–2155.

Schroeder S , Enderle MD , Ossen R et al. Noninvasive determination of endothelium-mediated vasodilation as a screening test for coronary artery disease: pilot study to assess the predictive value in comparison with angina pectoris, exercise electrocardiography, and myocardial perfusion imaging. Am Heart J 1999; 138: 731–739.

Raza K , Thambyrajah J , Townend JN et al. Suppression of inflammation in primary systemic vasculitis restores vascular endothelial function: lessons for atherosclerotic disease? Circulation 2000; 102: 1470–1472.

Filer AD , Gardner-Medwin JM , Thambyrajah J et al. Diffuse endothelial dysfunction is common to ANCA associated systemic vasculitis and polyarteritis nodosa. Ann Rheum Dis 2003; 62: 162–167.

10.

Lima DS , Sato EI , Lima VC et al. Brachial endothelial function is impaired in patients with systemic lupus erythematosus. J Rheumatol 2002; 29: 292–297.

11.

El Magadmi M , Bodill H , Ahmad Y et al. Systemic lupus erythematosus: an independent risk factor for endothelial dysfunction in women. Circulation 2004; 110: 399–404.

12.

Tan EM , Cohen AS , Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271–1277.

13.

Isenberg DA , Gordon C . From BILAG to BLIPS: disease activity assessment in lupus past, present and future. Lupus 2000; 9: 651–654.

14.

Gladman DD , Urowitz MB , Goldsmith CH et al. The reliability of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index in patients with systemic lupus erythematosus. Arthritis Rheum 1997; 40: 809–813.

15.

Rajman I , Kendall MJ , Cramb R et al. Investigation of low density lipoprotein subfractions as a coronary risk factor in normotriglyceridaemic men. Atherosclerosis 1996; 125: 231–242.

16.

Nourooz-Zadeh J , Tajaddini-Sarmadi J , Wolff SP . Measurement of plasma hydroperoxide concentrations by the ferrous oxidation-xylenol orange assay in conjunction with triphenylphosphine. Anal Biochem 1994; 220: 403–419.

17.

Hay EM , Bacon PA , Gordon C et al. The BILAG index: a reliable and valid instrument for measuring clinical disease activity in systemic lupus erythematosus. Q J Med 1993; 86: 447–458.

18.

Esdaile JM , Abrahamowicz M , Grodzicky T et al. Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Rheum 2001; 44: 2331–2337.

19.

Ross R . Atherosclerosis – an inflammatory disease. N Engl J Med 1999; 340: 115–126.

20.

Sanada M , Higashi Y , Nakagawa K et al. Comparison of forearm endothelial function between premenopausal and postmenopausal women with or without hypercholesterolemia. Maturitas 2003; 44: 307–315.

21.

McCrohon JA , Woo KS , Celermajer DS . A comparison of endothelial function in Caucasian and Chinese women before and after the menopause. Maturitas 2000; 35: 31–37.